Clinical

Dataset Information

Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients


ABSTRACT: The goal of this clinical trial] is to compare in resectable stage T3-4N2 colorectal cancer. The main question it aims to answer is: whether the use of targeted therapy in combination with adjuvant chemotherapy is associated with improved disease-free survival (DFS) compared to adjuvant chemotherapy alone.

DISEASE(S): Chemotherapy Effect,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 13676 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR